CAS: 96068-42-7
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol REF: 3D-WDA06842CAS: 96068-42-7 | Min. 95% | 180,00 €~789,00 € | Ven 14 Mar 25 |
 | SARS-CoV-2-IN-32 REF: TM-T63181CAS: 96068-42-7 | - - - | 2.023,00 €~3.328,00 € | Ven 28 Mar 25 |
4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol
CAS:96068-42-7
Please enquire for more information about 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol including the price, delivery time and more detailed …
Formula:
C27H23N5O4
Purezza:
Min. 95%
Peso molecolare:
481.5 g/mol
Ref: 3D-WDA06842
| 25mg | 341,00 € | ||
| 50mg | 338,00 € | ||
| 100mg | 526,00 € | ||
| 250mg | 789,00 € |
Consegna stimata in Stati Uniti, il Venerdì 14 Marzo 2025
SARS-CoV-2-IN-32
CAS:96068-42-7
SARS-CoV-2-IN-32 inhibits COVID-19 (Mpro; PDB: 6LU7) and has anti-cancer effects; useful for related research.
Formula:
C27H23N5O4
Colore e forma:
Liquid
Peso molecolare:
481.5
Ref: TM-T63181
| 25mg | 2.023,00 € | ||
| 50mg | 2.633,00 € | ||
| 100mg | 3.328,00 € |
Consegna stimata in Stati Uniti, il Venerdì 28 Marzo 2025
